Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo.

A Schepers; D Eefting; P I Bonta; J M Grimbergen; M R de Vries; V van Weel; C J de Vries; K Egashira; J H van Bockel; P H A Quax

doi:10.1161/01.ATV.0000235694.69719.e2

Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo.

Identifier:nobleid.org/w1/20260515/67ED11DF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/67ED11DF.svg?ark=w1%2F20260515%2F67ED11DF)](https://nobleid.org/work/w1/20260515/67ED11DF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo.

Identifier:nobleid.org/w1/20260515/67ED11DF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/67ED11DF.svg?ark=w1%2F20260515%2F67ED11DF)](https://nobleid.org/work/w1/20260515/67ED11DF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work